TNF and rheumatoid arthritis: In the analysis of patients using anti-TNF-α antibodies against underlying diseases such as rheumatoid arthritis (RA) or Crohn’s disease, disseminated TB, past TB infection, and corticosteroid use at the time of diagnosis have been reported as the risk factors of IRIS development [9].